Somatostatin receptor scintigraphy of non-neuroendocrine malignancies with 111In-pentetreotide

Anticancer Research

Volumn 17, Issue 3 B, 1997, Pages 1593-1597

  Limouris, Georgios S ^a   Rassidakis, Antonios ^b   Kondi Paphiti, Agathe ^a   Triantafyllou, Nicolaos ^c   Manetou, Angeliki ^d   Giannakopoulos, Vassilios ^a   Toubanakis, Nicolaos ^a   Psyhojios, Ioannis ^a   Stavraka, Anastasia ^a   Vlahos, Lambros ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d NIMTS HOSPITAL   (Greece)

Author keywords

111In pentetreotide; Non neuroendocrine malignancies; Scintigraphy; Somatostatin receptor

Indexed keywords

PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; ARTICLE; ASTROCYTOMA; AXILLARY LYMPH NODE; BRAIN TUMOR; BREAST TUMOR; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DRUG ACCUMULATION; DRUG DISTRIBUTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LYMPHOMA; LYMPHOSCINTIGRAPHY; MALE; MELANOMA; MENINGIOMA; PRIORITY JOURNAL; RADIODIAGNOSIS; RECEPTOR AFFINITY; SCINTIGRAPHY; THYROID TUMOR; TISSUE CHARACTERIZATION; TUMOR BIOPSY;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; LYMPHATIC METASTASIS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; RECEPTORS, SOMATOSTATIN; SKIN NEOPLASMS; SOMATOSTATIN; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030993076     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Reubi JC, Waser B, Horisberger U, Krennig EEP, Lamberts SWJ, Gebbers JO, Gersbach P, Laissue JA: In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood 82: 2143-2151, 1993.
2. Reubi TC, Horisberger U, Studder UE, Waser B, Laissue JA: Human kidney as target for somatostatin: High affinity receptors in tubules and vasa recta. J Clin Endocinol Metab 17: 1323-1328, 1993.
3. Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB: All five cloned somatostatin receptors are functionally coupled to adenyl cyclase. Biochem Biophys Res Comm 198: 605-612, 1994.
4. Stansfield AG, Diebold J, Noel H: Uptake Kiel classification for lymphomas. Lancet 603: 292-293, 1988.
5. Luyken C, Hildebrandt G, Scheidhauer K, Krisch B, Schida H, Klug N: Indium-111 (DTPA-octreotide) scintigraphy in patients with cerebral gliomas. Acta Neurochir (Wien) 127: 60-64, 1994.
6. Scheidhauer K, Luyken C, Hildebrand T: Somatostatin-receptor-imaging in intracranial tumors [Abstract]. Eur J Nucl Med 20: 883, 1993.
7. Jong DL, Dong IK, Jong TL, Jin WC, Chang YP: Indium-111-pentetreotide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI. J Nucl Med 5: 36: 537-541, 1995.
8. Haldemann RA, Rösler H, Barth A, Waser B, Geiger L, Godoy N, Markwalder VR, Seiler WR, Sulzer M, Reubi J-C: Somatostatin receptor scintigraphy in central nervous system tumors: Role of blood-brain barrier permeability. J Nucl Med 36: 403-410, 1995.
9. Reubi J-C: Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging. J Nucl Med 36: 1825-1835, 1995.
10. Limouris GS, Giannakopoulos V, Athanassiades S, Stavraka A: The efficacy of In-111 pentetreotide in breast cancer staging [Abstract]. Eur J Nucl Med 21(8): 855, 1994.
11. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20(8): 716-731, 1993.
12. Kvols LK, Krenning EP, Kwekkeboom DJ, Pawels S, Reubi J-C: Somatostatin receptor scintigraphy. In: Limouris GS, Shukla SK, Biersack H-J (eds): Radionuclides for Receptors, Mediterra Pbls, Athens, pp 137-146, 1995.
13. Reubi J-C, Laissue JA: Multiple pathways of somatostatin action in neoplastic disease. Trends Pharmacol Sci 16: 110-115, 1995.
14. Lamberts SWJ: Somatostatin receptors in breast cancer.Lancet 343: 640-644, 1994.
15. Lamberts SWJ, Krenning EP, Reubi J-C: The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12: 450-482, 1991.
16. Van Hagon PM, Krennig EP, Reubi J-C Mulder AH, Bakker WH, Oei HY, Löwenberg B, Lamberts SWJ: Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol 83: 75-79, 1993.
17. Sarda L, Duet M, Zini JM, Berolatti B, Benelhadj S, Tobelem G, Mundler O: Indium-111 pentetreotide scintigraphy in malignant lymphomas. Eur J Nucl Med 22: 1105-1109, 1995.
18. Krenning EP, Lamberts SWJ, Reubi J-C: Neurocndocrine and Other Tumors, in: Wagner HN, Szabo Z, Buchanan ZW (eds): Principles of Nuclear Medicine, WB Saunders Co, Philadelphia, pp 1104-1110, 1995.
19. Reubi J-C, Waser B, Van Hagen M: In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancor 50: 895-900, 1992.
20. Baudin E, Lumbroso J, Schlumberger M, Loclorc J, Giammarile F, Gardot P, Roche A, Travagli JP, Parmontier C: Comparison of octreotide scintigraphy and convontional imaging in medullary thyroid carcinoma. J Nucl Med 37(6): 912-916, 1996.
21. Ain KB, Taylor KD: Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78: 1097-1102, 1994.